JP2015502974A5 - - Google Patents

Download PDF

Info

Publication number
JP2015502974A5
JP2015502974A5 JP2014548243A JP2014548243A JP2015502974A5 JP 2015502974 A5 JP2015502974 A5 JP 2015502974A5 JP 2014548243 A JP2014548243 A JP 2014548243A JP 2014548243 A JP2014548243 A JP 2014548243A JP 2015502974 A5 JP2015502974 A5 JP 2015502974A5
Authority
JP
Japan
Prior art keywords
compound according
pharmaceutical composition
infection
microbial
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014548243A
Other languages
English (en)
Japanese (ja)
Other versions
JP6031122B2 (ja
JP2015502974A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2012/002880 external-priority patent/WO2013093615A1/en
Publication of JP2015502974A publication Critical patent/JP2015502974A/ja
Publication of JP2015502974A5 publication Critical patent/JP2015502974A5/ja
Application granted granted Critical
Publication of JP6031122B2 publication Critical patent/JP6031122B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014548243A 2011-12-22 2012-12-20 抗微生物療法のための三環式ホウ素化合物 Expired - Fee Related JP6031122B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161579271P 2011-12-22 2011-12-22
US61/579,271 2011-12-22
PCT/IB2012/002880 WO2013093615A1 (en) 2011-12-22 2012-12-20 Tricyclic boron compounds for antimicrobial therapy

Publications (3)

Publication Number Publication Date
JP2015502974A JP2015502974A (ja) 2015-01-29
JP2015502974A5 true JP2015502974A5 (cg-RX-API-DMAC7.html) 2016-02-12
JP6031122B2 JP6031122B2 (ja) 2016-11-24

Family

ID=47664367

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014548243A Expired - Fee Related JP6031122B2 (ja) 2011-12-22 2012-12-20 抗微生物療法のための三環式ホウ素化合物

Country Status (7)

Country Link
US (1) US8530452B2 (cg-RX-API-DMAC7.html)
EP (1) EP2793901A1 (cg-RX-API-DMAC7.html)
JP (1) JP6031122B2 (cg-RX-API-DMAC7.html)
KR (1) KR20140114380A (cg-RX-API-DMAC7.html)
CN (1) CN104136032B (cg-RX-API-DMAC7.html)
CA (1) CA2858799A1 (cg-RX-API-DMAC7.html)
WO (1) WO2013093615A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9585396B2 (en) 2013-01-30 2017-03-07 Agrofresh Inc. Volatile applications against pathogens
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
MX356059B (es) * 2013-01-30 2018-05-11 Dow Agrosciences Llc Uso de benzoxaboroles como agentes antimicrobianos volatiles en carnes, plantas, o partes de plantas.
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
KR101636431B1 (ko) * 2013-07-30 2016-07-05 동아에스티 주식회사 트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도
DK3030519T3 (da) * 2013-08-09 2022-01-31 Glaxosmithkline Ip No 2 Ltd Tricykliske benzoxaborol-forbindelser og anvendelser deraf
EA038093B1 (ru) * 2013-12-20 2021-07-05 Глаксосмитклайн Интеллекчуал Проперти (№2) Лимитед Способ лечения заболевания, вызванного инфекцией комплекса mycobacterium tuberculosis, с использованием (s)-(3-хлор-7,8-дигидро-2h-1,6,9-триокса-9a-борабензо[cd]азулен-2-ил)метанамина или его фармацевтически приемлемой соли
TW201625649A (zh) 2014-07-01 2016-07-16 第一三共股份有限公司 作爲抗菌劑的三環化合物
CN104177226A (zh) * 2014-07-31 2014-12-03 河北国蓬化工有限公司 一种聚醚用催化剂的制备方法
MA41495A (fr) * 2015-02-12 2017-12-19 Anacor Pharmaceuticals Inc Composés benzoxaborole et leurs utilisations
WO2017155879A1 (en) 2016-03-07 2017-09-14 Agrofresh Inc. Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
KR101925338B1 (ko) 2016-12-22 2018-12-05 엘에스산전 주식회사 전력기기 진단 장치
EP3850029A1 (en) 2019-08-09 2021-07-21 Safas Saf Plastik Sanayi Ve Ticaret Anonim Sirketi Boron-modified flexible polyurethane foam for hygiene and a method of production therefor
EP4384527A4 (en) * 2022-06-23 2025-09-03 Micurx Pharmaceuticals Inc PRODRUGS OF BORON COMPOUNDS AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS
AU2023287202A1 (en) 2022-06-23 2024-06-06 Shanghai Micurx Pharmaceutical Co., Ltd. Methods and uses of boron compounds in the treatment of nontuberculous mycobacterium infections and pharmaceutical compositions for treatment of same
WO2025140370A1 (zh) * 2023-12-27 2025-07-03 上海盟科药业股份有限公司 硼化合物前药的盐型、晶型及其药物组合物和用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5011472A (en) 1988-09-06 1991-04-30 Brown University Research Foundation Implantable delivery system for biological factors
CA2529792A1 (en) 2003-06-16 2005-02-17 Anacor Pharmaceuticals, Inc. Hydrolytically-resistant boron-containing therapeutics and methods of use
DK1988779T5 (en) * 2006-02-16 2016-10-10 Anacor Pharmaceuticals Inc SMALL boron MOLECULES AS ANTI-INFLAMMATORY AGENTS
BRPI0711155A2 (pt) 2006-05-02 2011-08-23 Anacor Pharmaceuticals Inc terapêuticos contendo boro resistentes hidroliticamente e métodos de uso
US20070286822A1 (en) * 2006-06-12 2007-12-13 Anacor Pharmaceuticals Inc. Compounds for the Treatment of Periodontal Disease
JO3396B1 (ar) * 2007-06-20 2019-10-20 Anacor Pharmaceuticals Inc جزيئات صغيرة تحتوي على البورون
US20100256092A1 (en) 2008-05-12 2010-10-07 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
US20110259250A1 (en) 2008-08-21 2011-10-27 Mcknight James T Systems And Methods For Converting Biomass In The Field To A Combustible Fluid For Direct Replacement Or Supplement To Liquid Fossil Fuels
KR20110111407A (ko) * 2008-12-17 2011-10-11 아나코르 파마슈티칼스 인코포레이티드 (s)-3-아미노메틸-7-(3-히드록시-프로폭시)-3h-벤조〔c〕〔1,2〕옥사보롤-1-올의 다형태
EP2458995A1 (en) 2009-07-28 2012-06-06 Anacor Pharmaceuticals, Inc. Trisubstituted boron-containing molecules
MX352607B (es) 2010-04-07 2017-11-30 Glaxosmithkline Llc Star Proceso para la preparacion de benzoxaboroles.
BR112013005426B1 (pt) 2010-09-07 2021-08-24 Anacor Pharmaceuticals, Inc Composto, composição, combinação, e, formulação farmacêutica

Similar Documents

Publication Publication Date Title
JP2015502974A5 (cg-RX-API-DMAC7.html)
JP2018518537A5 (cg-RX-API-DMAC7.html)
JP2013542992A5 (cg-RX-API-DMAC7.html)
JP2013542247A5 (cg-RX-API-DMAC7.html)
SA520411571B1 (ar) مركبات كرومان مونوباكتام لعلاج العدوى البكتيرية
JP2014521735A5 (cg-RX-API-DMAC7.html)
JP2013541514A5 (cg-RX-API-DMAC7.html)
JP2015521617A5 (cg-RX-API-DMAC7.html)
JP2013510120A5 (cg-RX-API-DMAC7.html)
JP2014507477A5 (cg-RX-API-DMAC7.html)
RU2013148721A (ru) Комбинации соединений, ингибирующих акт и вемурафениба и способы их применения
EA201100305A1 (ru) Лечение респираторных заболеваний
JP2016534063A5 (cg-RX-API-DMAC7.html)
JP2020507589A5 (cg-RX-API-DMAC7.html)
MX2010007374A (es) Nuevos derivados de c-21-ceto lupano, preparacion y uso de los mismos.
MX2012000488A (es) Terapia de combinacion para el tratamiento de la diabetes.
AR090885A1 (es) Uso de laquinimod en alta dosis para el tratamiento de la esclerosis multiple
JP2011505356A5 (cg-RX-API-DMAC7.html)
JP2013509441A5 (cg-RX-API-DMAC7.html)
RU2014150942A (ru) Лечение побочных эффектов в виде моторных и двигательных расстройств, связанных с лечением болезни паркинсона
JP2015516419A5 (cg-RX-API-DMAC7.html)
JP2008534453A5 (cg-RX-API-DMAC7.html)
JP2017529357A5 (cg-RX-API-DMAC7.html)
JP2013528659A5 (cg-RX-API-DMAC7.html)
JP2012508256A5 (cg-RX-API-DMAC7.html)